CME Group Inc (NASDAQ:CME) CFO John W. Pietrowicz sold 7,500 shares of the stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total value of $1,136,250.00. Following the transaction, the chief financial officer now owns 32,376 shares of the company’s stock, valued at $4,904,964. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of CME Group Inc (CME) opened at $152.73 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05. The company has a market capitalization of $51,820.16, a price-to-earnings ratio of 31.97, a PEG ratio of 2.04 and a beta of 0.72. CME Group Inc has a 1-year low of $114.82 and a 1-year high of $155.29.
CME Group (NASDAQ:CME) last announced its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.05 earnings per share. research analysts expect that CME Group Inc will post 4.76 EPS for the current fiscal year.
The company also recently declared a dividend, which will be paid on Tuesday, January 16th. Investors of record on Thursday, December 28th will be issued a $3.50 dividend. This is a boost from CME Group’s previous dividend of $3.25. The ex-dividend date is Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is currently 59.86%.
CME has been the subject of several recent analyst reports. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays increased their target price on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a report on Tuesday, January 2nd. Royal Bank of Canada increased their target price on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Finally, Keefe, Bruyette & Woods restated a “hold” rating and set a $133.00 target price on shares of CME Group in a report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $144.22.
Institutional investors have recently bought and sold shares of the stock. Fiduciary Trust Co. bought a new position in CME Group in the second quarter valued at about $105,000. Quadrant Capital Group LLC boosted its holdings in CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares during the last quarter. Valeo Financial Advisors LLC bought a new position in CME Group in the third quarter valued at about $124,000. San Francisco Sentry Investment Group CA bought a new position in CME Group in the second quarter valued at about $129,000. Finally, People s United Financial Inc. boosted its holdings in CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 110 shares during the last quarter. Institutional investors and hedge funds own 82.70% of the company’s stock.
WARNING: This report was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://ledgergazette.com/2018/01/13/insider-selling-cme-group-inc-cme-cfo-sells-1136250-00-in-stock.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.